Wormiza 1000mg

Wormiza 1000mg is the highest single-tablet dose of fenbendazole available, designed for users following protocols that target 1 gram per day. The Joe Tippens self-administration protocol (1000mg per day, 3 days on, 4 days off, repeated weekly) is the single most common reason adult users seek 1g fenbendazole tablets, and Wormiza 1000mg delivers that target dose in one swallow rather than splitting two 500mg or three 333mg-equivalent tablets. Actiza Pharmaceutical Pvt. Ltd. manufactures Wormiza 1000mg at a WHO-GMP certified facility in India.

Why a 1000mg single-tablet dose matters

Fenbendazole has very low oral bioavailability in humans (less than 1 percent for the parent compound), with active metabolites oxfendazole and fenbendazole sulphone contributing most of the systemic effect. Taking the daily dose as one tablet rather than two reduces dosing-time variability and improves protocol compliance over multi-week regimens. A 2024 review of oral fenbendazole in humans summarises pharmacokinetic data and self-administration patterns across the published literature (PMID:39197912).

For protocols below 1g daily, lower-strength Wormiza variants fit better: Wormiza 222mg for the original 222mg-per-day protocol, Wormiza 444mg for moderate-burden treatment, and Wormiza 500mg if your protocol targets 500mg daily. For the 888mg dose used in some hookworm and giardia regimens, Wormentel 888mg is the matching tablet.

The state of human fenbendazole evidence in 2025

Fenbendazole is approved worldwide for veterinary use and is not currently approved by the FDA for any human indication. Published interest in human off-label use has expanded sharply in the last three years. A 2025 case series describes three patients who self-administered fenbendazole over multiple months with clinical follow-up and safety monitoring (PMID:40605964). A 2025 experimental study examined nanosuspensions of fenbendazole and ivermectin in animal models of neurocysticercosis, exploring formulation improvements that increase bioavailability (PMID:40783068).

For antiparasitic use, a 2024 study in adult horses showed reduced efficacy of fenbendazole and ivermectin against certain strongyle populations, reflecting growing resistance in veterinary populations (PMID:37952299). A 2023 comparative trial against canine hookworm (ancylostomiasis) found ivermectin and fenbendazole both effective with a slight ivermectin advantage (PMID:36910310). None of this evidence base translates directly to FDA-approved human treatment claims.

How users typically take Wormiza 1000mg

The most common pattern in published self-administration reports is one Wormiza 1000mg tablet daily for 3 consecutive days, followed by 4 days off, then repeated weekly. The tablet is taken with a fatty meal because fenbendazole absorption increases roughly 4 to 5 fold with fat coadministration. Some users add curcumin, vitamin E, or CBD as part of broader stacked protocols; the evidence base for these adjuncts is limited to anecdote rather than controlled trials.

For a step-by-step breakdown of the original Tippens regimen, see our Joe Tippens fenbendazole protocol guide. For weight-adjusted dosing calculations, our fenbendazole dosage calculator covers the math. For protocol scheduling and timing specifics, see how to take fenbendazole protocol.

Safety, side effects, and what to monitor

Fenbendazole has an extremely benign acute toxicity profile in humans at protocol doses; the LD50 in animal models is above 5000 mg/kg orally, and human self-administration reports at 1000mg daily have generally not shown acute toxicity. Reported side effects in human users include mild gastrointestinal upset, transient elevation of liver transaminases, and occasional headache. Long-term human safety data at sustained protocol doses are limited, and baseline plus periodic liver function testing is the most common monitoring recommendation in published case reports.

Avoid fenbendazole if you have pre-existing hepatic impairment, are pregnant or breastfeeding, or take warfarin (theoretical CYP-mediated interaction possible). Always disclose fenbendazole use to your treating physician; it interacts pharmacokinetically with multiple drugs through CYP3A4 and may interfere with chemotherapy regimens. For deeper safety reading, see our fenbendazole for humans safety guide.

Combining with ivermectin

Some users follow combination protocols that pair fenbendazole with ivermectin on alternating days, based on the rationale that the two drugs target different parasitic mechanisms (microtubule disruption versus glutamate-gated chloride channels). For combined-dosing convenience, Wormentel Duo 156mg packages both active ingredients in one tablet. For ivermectin separately, Ivercor 12mg is the standard 60 kg adult dose. Our combined ivermectin and fenbendazole protocol guide walks through the most common schedules.

Order Wormiza 1000mg to USA, UK, Australia and Canada

SafeRxPills ships Wormiza 1000mg in plain, unmarked packaging to the United States, United Kingdom, Australia and Canada within 7 to 14 business days. Every order ships from a WHO-GMP certified Actiza Pharmaceutical batch with tracking from dispatch to delivery. For brand background, see our Wormiza brand guide for US patients.